HMGB1 induces macrophage pyroptosis in chronic endometritis
International Immunopharmacology · 2023-10 · 123 · 110706
DOI: 10.1016/j.intimp.2023.110706 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-10. Verfasst von Guoxia Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medical Center, The First Affiliated Hospital of Sun Yat-sen University, China; Guangdong Provincial Key Laboratory of Reproductive Medi…. Hauptthemen laut MEDLINE: Endometritis, HMGB1 Protein, Pyroptosis. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
BACKGROUND: Chronic endometritis (CE) reflects the local imbalance in the endometrial immune microenvironment after inflammation. High mobility group box 1 (HMGB1) is highly involved in both immunity and inflammation. In this study, we aimed to explore the roles of HMGB1 in the endometrium of patients with CE. METHODS: Endometrium and uterine fluid HMGB1 were tested in a cohort of infertile patients with or without CE. Expression levels of the pyroptosis marker, gasdermin D (GSDMD)-N-terminal (NT), in the human endometrium of patients with CE and controls were determined. Next, the role of HMGB1 as a driver of macrophage pyroptosis was investigated using human THP-1 cells in vitro and a CE mouse model in vivo. RESULTS: High expression levels of HMGB1 in biopsied endometrial tissue and uterine fluid were confirmed in a cohort of patients with CE. Positive correlation between the number of CD138+ cells and HMGB1 mRNA expression level were detected (rs = 0.592, P < 0.001). Meanwhile, we found that GSDMD-NT expression was significantly increased in the CE endometrium at both the transcriptional and translational levels. Moreover, co-localization of GSDMD-NT and macrophages was confirmed via the double immunostaining of GSDMD-NT and CD68. In vitro experiments revealed that macrophage pyroptosis was induced by HMGB1 in human THP-1-derived macrophages. Treatment with glycyrrhizic acid, an inhibitor of HMGB1, significantly suppressed endometrial pyroptosis and inflammation in the CE mouse model. CONCLUSIONS: HMGB1 effectively induced macrophage pyroptosis in the human endometrium, suggesting that its inhibition may serve as a novel treatment option for CE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medical Center, The First Affiliated Hospital of Sun Yat-sen University, China; Guangdong Provincial Key Laboratory of Reproductive Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzh…
- Guangdong Provincial Clinical Research Center for obstetrical and gynecological diseases, China; Department of Obstetrics and Gynecology, The First Affiliated Hospital of Sun Yat-sen University, China.
- Department of Reproductive Medicine, The First People's Hospital of Yunnan Province, Kunming, Yunnan, China; NHC Key Laboratory of Periconception Health Birth in Western China, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Yang, G., Zhang, Q., Tan, J., Xiong, Y., Liang, Y., Yan, J., Gu, F., & Xu, Y. (2023). HMGB1 induces macrophage pyroptosis in chronic endometritis. International Immunopharmacology, 123, 110706. https://doi.org/10.1016/j.intimp.2023.110706
Vancouver
Yang G, Zhang Q, Tan J, Xiong Y, Liang Y, Yan J, et al. HMGB1 induces macrophage pyroptosis in chronic endometritis. International Immunopharmacology. 2023;123:110706. doi:10.1016/j.intimp.2023.110706
BibTeX
@article{Yang2023,
author = {Yang, Guoxia and Zhang, Qingyan and Tan, Jinfeng and Xiong, Yujing and Liang, Yanchun and Yan, Jiacong and Gu, Fang and Xu, Yanwen},
title = {HMGB1 induces macrophage pyroptosis in chronic endometritis},
journal = {International Immunopharmacology},
year = {2023},
volume = {123},
pages = {110706},
doi = {10.1016/j.intimp.2023.110706}
}
EUVIMED